Clinical Trial Update: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on AAVRh.10 administration in children with Late Infantile Neuronal Ceroid Lipofuscinosis (Batten disease) spanning Phase 1 and Phase 2, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Batten Disease
• Late-infantile Neuronal Ceroid Lipofuscinosis

Drugs mentioned

• AAVRh.10

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Late Infantile Neuronal Ceroid Lipofuscinosis, Batten Disease | Phase 1, Phase 2 | Status: COMPLETED